NCT02915575

Brief Summary

The purpose of this trial is to test the clinical benefit and feasibility of structured risk based post discharge care for hospital acquired Acute kidney injury survivors.This is a Pragmatic randomized controlled trial. It will be conducted at 2 hospitals in Alberta. 166 participants will be enrolled in this Randomized controlled trial..

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
155

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 27, 2016

Completed
1.5 years until next milestone

Study Start

First participant enrolled

March 19, 2018

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

March 3, 2025

Status Verified

February 1, 2025

Enrollment Period

5.8 years

First QC Date

September 22, 2016

Last Update Submit

February 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients develop Chronic kidney disease after Acute kidney injury

    The primary (process based) outcome of this trial is the proportion of patients with CKD meeting all three quality of care indicators (statin use, ACEi/ARB use in those with proteinuria (ACR\>30mg/mmol) or diabetes, nephrologist visit if sustained eGFR\<30ml/min/1.73m2) within 90 days of hospital

    90 days

Secondary Outcomes (4)

  • Proportion of patients completed the lab and seen by PCP

    90 days

  • check eGFR

    one year

  • Hospitalization

    one year

  • Feasibility

    one year

Study Arms (2)

Control Arm (usual care)

OTHER

Participants will be discharged as per usual ward discharge protocols.

Other: Usual Care

Risk guided follow-up

OTHER

Participant will be stratified for risk of CKD in three groups: Low (\<1% risk of CKD), medium (1-10 % risk of CKD) and high (≥10 % risk of CKD). Specific follow-up will be guided by risk status

Other: Risk guided follow-up

Interventions

Participant will be stratified for risk of CKD in three groups: Low (\<1% risk of CKD), medium (1-10 % risk of CKD) and high (≥10 % risk of CKD). Specific follow-up will be guided by risk status

Risk guided follow-up

Participants will be discharged as per usual ward discharge protocols.

Control Arm (usual care)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 yrs
  • At least a doubling of serum creatinine during hospitalization (including need for dialysis)
  • Have a primary care physician (PCP)
  • No nephrologist follow up arranged after hospital discharge

You may not qualify if:

  • Baseline GFR\<30ml/min/1.73m2(CKD-EPI) or requiring chronic dialysis on admission
  • Renal transplant recipients
  • Poor prognosis not expected to survive \> 6 months
  • Residence at a nursing home facility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Foothills Hospital

Calgary, Alberta, Canada

Location

University of Alberta hospital

Edmonton, Alberta, T6G 2B7, Canada

Location

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Neesh Pannu, MD

    University of Alberta

    PRINCIPAL INVESTIGATOR
  • Matthew James, MD

    Foothills Medical Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2016

First Posted

September 27, 2016

Study Start

March 19, 2018

Primary Completion

December 31, 2023

Study Completion

November 30, 2024

Last Updated

March 3, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations